Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
about
Pharmacological interventions for the treatment of delirium in critically ill patientsAdverse childhood experiences and prescribed psychotropic medications in adultsPotential drug-drug interactions in Alzheimer patients with behavioral symptomsApplications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?DementiaPharmacological and nonpharmacological management of delirium in critically ill patients.The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical reviewAssessment and management of behavioral and psychological symptoms of dementiaDid FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend AnalysisEffect of music intervention on the cognitive and depression status of senior apartment residents in TaiwanPerceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care.Dementia.Continuous use of antipsychotics and its association with mortality and hospitalization in institutionalized Chinese older adults: an 18-month prospective cohort study.The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's diseaseRationale, design and baseline data for the Activating Consumers to Exercise through Peer Support (ACE trial): A randomized controlled trial to increase fitness among adults with mental illness.Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationshipsPsychotropic medication use among nursing home residents in Austria: a cross-sectional study.Psychiatric Aspects of Dementia.Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations.Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary interventionUse of instrumental variable in prescription drug research with observational data: a systematic review.The differential impact of delivery hospital on the outcomes of premature infants.Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trialsTrends in use of antipsychotics in elderly patients with dementia: Impact of national safety warningsAntipsychotic use varies by patient age.Reference drug programs: effectiveness and policy implications.Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.Instrumental variable methods in comparative safety and effectiveness researchImpact of prescribed medications on patient safety in older people.Patterns and trends in antipsychotic prescribing for Parkinson disease psychosisInstrumental variable applications using nursing home prescribing preferences in comparative effectiveness researchDevelopments in post-marketing comparative effectiveness researchMultivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databasesQuantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Clinical pharmacology and vascular risk.Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.Psychotropic and psychoactive drugs and hospitalization rates in nursing facility residents.
P2860
Q24187548-1582C206-57D5-49A3-B88D-8BD4D5E68FD6Q24630928-F6E15196-BB49-4613-90C5-57C0EE6529A4Q26782490-2843215E-DF84-4BF2-B38D-868DCA4B1A8BQ26849372-F97DF90F-BE17-4F91-99D5-7AD1CE286478Q26860881-BB52A19D-7E66-4113-8C17-0F6F51629002Q27005223-A9A61698-CCEB-4210-95DC-9332B82EFB56Q27022753-773FECA5-184B-48EC-A13E-57ACCF686221Q28088782-702E7E1B-8E1E-47EC-BBAB-38010C7ADD0BQ28551085-801BE0AB-FD4C-43DD-B6B9-355CFD190E1DQ30376053-32A75D98-113F-4047-BD4B-FB0F56410145Q30397374-5169A67B-8A59-413D-9465-12AAA79B35A2Q30404451-F4D4C0DB-F311-4FD1-8C7C-811FFBE62741Q30406882-3B78AE89-ADC7-4A35-8694-70A4C3400C2FQ30413790-5E38F695-BC7A-4513-9135-24FA267B58C9Q30597086-A5F22267-6EA1-4DDD-9CFD-42AAC22FB92BQ33248004-0ACB303E-5C4A-4EBE-90E4-CFAF7B6650E0Q33403317-C646283E-EB7F-4167-90A1-295119732CA4Q33428425-309AEA4A-496B-4842-8297-6F06F57D23ADQ33449888-FFBA3CC5-F62D-450C-A6F5-BCE6DD6B920DQ33562417-35777F28-6E2C-4759-9617-10B991C21FBFQ33617259-AAF940D7-4600-40D7-8E45-578EB2D52C90Q33693126-633D6457-1A7D-4006-9734-C764EC0D62ECQ33701953-0BDDBDE4-E787-46EC-976B-E484E3AFF75BQ33773119-FB0BCFD0-FC78-4462-ABF5-57F77FAAE7EDQ33819482-88C6DA68-F458-454D-B9D4-FA1F586D2741Q33874525-F96B0BC4-4DE5-4DAC-9947-B34C916E65C3Q33888723-E9FBC3B8-5263-4CED-B8EE-D2B3BB395B36Q33894639-D70A70BF-E75F-45A3-B84C-425903643BA7Q33908085-27946E3D-2301-45F7-AD07-F3879C68E1CCQ33914708-D5872126-672C-4A3A-858E-34AF3C999294Q33915337-B25869BB-FAEA-4E72-83BF-CE33EE2B5585Q33949432-C931A26B-0BDD-4F80-91DE-EF4A082AD28DQ33957582-B680F94A-0A1E-46AE-AD27-8CD6C9B2753CQ33976565-36EE979D-79B4-4BB4-AB3F-D5FCC72D1199Q34001867-9A912758-C8A6-4B08-BF34-3811FC51107DQ34039973-6294A0FC-677A-4859-813A-4FDC026415FBQ34070862-10C11FAE-2F9D-450D-9706-C5870DFDA11AQ34072168-C58BBAB9-3E61-41B1-86B8-918F9A729965Q34103436-614EC01D-E683-4874-908E-ABA9769BAFA5Q34134089-9AC62A2B-7C57-42A1-B8E7-A4177B439BD8
P2860
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@ast
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@en
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@nl
type
label
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@ast
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@en
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@nl
prefLabel
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@ast
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@en
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@nl
P2093
P356
P1476
Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
@en
P2093
Daniel H Solomon
Helen Mogun
Jerry Avorn
M Alan Brookhart
Michael A Fischer
Philip S Wang
Sebastian Schneeweiss
P304
P356
10.1056/NEJMOA052827
P407
P577
2005-12-01T00:00:00Z